Journal
Molecular Therapy
ISSN 1525-0016 · Elsevier BV
Published here
10 counted works of 10 linked
| Year | Title | Academics | Sources |
|---|---|---|---|
| 2026 | Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model | David R. Liu | CV |
| 2025 | Systematic Empirical Evaluation of Individual Base Editing Targets: Validating Therapeutic Targets in USH2A and Comparison of Methods | David R. Liu | CV |
| 2024 | Adenovirus Capsid-Based Anti-Fentanyl Vaccine Protects Against Fentanyl-Induced Cardio-Respiratory Depression | Tristan Lambert | GS |
| 2024 | Introducing a Hemoglobin G-Makassar Variant in HSCs by In Vivo Base Editing Treats Sickle Cell Disease in Mice | David R. Liu | CV |
| 2023 | Rescue of Hearing by Adenine Base Editing in a Humanized Mouse Model of Usher Syndrome Type 1F | David R. Liu | CV |
| 2022 | Adenovirus Capsid Proteins-Based Anti-Fentanyl Vaccine Attenuates Fentanyl-Induced Behaviors in Mice | Tristan Lambert | GS |
| 2022 | Disruption of HIV-1 Co-Receptors CCR5 and CXCR4 in Primary Human T Cells and Hematopoietic Stem and Progenitor Cells Using Base Editing | David R. Liu | CV |
| 2021 | Development of an Effective Anti-Fentanyl Vaccine Based on the Highly Immunogenic Adenovirus Capsid Proteins | Tristan Lambert | GS |
| 2021 | In Vivo Somatic Cell Base Editing and Prime Editing | David R. Liu | CV |
| 2011 | LiGluR Restores Visual Responses in Rodent Models of Inherited Blindness | Dirk Trauner | CV OA GS |